Beta Bionics (BBNX) Operating Expenses (2024 - 2026)

Beta Bionics' Operating Expenses history runs 3 years deep, the most recent figure standing at $40.7 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 47.42% year-over-year to $40.7 million; the TTM figure through Mar 2026 stood at $140.3 million (up 52.35% YoY), while the FY2025 annual figure was $127.2 million, up 56.79% from the prior year.
• Operating Expenses came in at $40.7 million for Q1 2026 at Beta Bionics, up from $35.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $40.7 million in Q1 2026 to a low of $16.7 million in Q1 2024.
• A 3-year average of $27.7 million and a median of $27.6 million in 2025 frame the typical range for Operating Expenses.
• On a YoY basis, Operating Expenses climbed as much as 65.8% in 2025 and fell as far as 41.83% in 2025.
• Beta Bionics' Operating Expenses stood at $24.7 million in 2024, then surged by 41.83% to $35.1 million in 2025, then increased by 16.08% to $40.7 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $40.7 million, $35.1 million, and $32.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison